Core Insights - H. B. Fuller reported revenue of $923.28 million for the quarter ended November 2024, reflecting a 2.3% increase year-over-year, while EPS decreased to $0.92 from $1.32 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $916.43 million by 0.75%, but the company did not meet EPS expectations, which were also $0.92 [1] Revenue Breakdown - Hygiene, Health and Consumable Adhesives generated net revenue of $395.69 million, slightly above the estimated $395.50 million, but down 3.7% year-over-year [4] - Construction Adhesives reported net revenue of $145.66 million, surpassing the average estimate of $136.35 million, marking a 15.6% increase year-over-year [4] - Engineering Adhesives achieved net revenue of $381.93 million, slightly above the estimated $380.51 million, with a 4.4% year-over-year increase [4] Adjusted EBITDA Performance - Adjusted EBITDA for Engineering Adhesives was $75.15 million, exceeding the average estimate of $74.58 million [4] - Adjusted EBITDA for Construction Adhesives was $17.89 million, below the average estimate of $18.75 million [4] - Adjusted EBITDA for Hygiene, Health and Consumable Adhesives was $54.97 million, significantly lower than the estimated $67.75 million [4] Stock Performance - H. B. Fuller shares have declined by 11.5% over the past month, compared to a 3.3% decline in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]
H. B. Fuller (FUL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates